Rosen, A Respected and Leading Firm, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - BMRNNewsfile Corp • 10/17/20
BIOMARIN CLASS ACTION UPDATE BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & FotI, LLC Reminds Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRNNewsfile Corp • 10/16/20
ROSEN, A TOP RANKED LAW FIRM, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - BMRNPRNewsWire • 10/15/20
BIOMARIN INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuit Against BioMarin Pharmaceutical Inc. - BMRNNewsfile Corp • 10/10/20
BMRN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BioMarin Pharmaceutical Inc. Shareholders of Class Action and Lead Plaintiff Deadline: November 24, 2020Business Wire • 10/08/20
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Deadline in Securities Class Action – BMRNBusiness Wire • 10/06/20
ROSEN, A TOP RANKED FIRM, Announces Filing of Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - BMRNNewsfile Corp • 10/05/20
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - BMRNPRNewsWire • 10/02/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioMarin Pharmaceuticals Inc. (BMRN) on Behalf of InvestorsBusiness Wire • 10/02/20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of BioMarin Pharmaceuticals Inc. (BMRN) InvestorsBusiness Wire • 10/02/20
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of BioMarin Pharmaceuticals Inc. (BMRN) InvestorsBusiness Wire • 10/01/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioMarin Pharmaceuticals Inc. (BMRN) on Behalf of InvestorsBusiness Wire • 10/01/20
The Law Offices of Frank R. Cruz Announces Investigation of BioMarin Pharmaceuticals Inc. (BMRN) on Behalf of InvestorsBusiness Wire • 10/01/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioMarin Pharmaceuticals Inc. (BMRN) on Behalf of InvestorsBusiness Wire • 10/01/20
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 09/30/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/29/20
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/28/20
BMRN INVESTIGATION ALERT: Bernstein Liebhard is Investigating BioMarin Pharmaceuticals For Violations of the Securities LawsBusiness Wire • 09/28/20
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc. – BMRNBusiness Wire • 09/28/20
BMRN LOSSES ALERT: Bernstein Liebhard is Investigating BioMarin Pharmaceuticals For Violations of the Securities LawsBusiness Wire • 09/28/20
Pomerantz Law Firm Announces the Filing of a Class Action against BioMarin Pharmaceuticals, Inc. and Certain Officers - BMRNPRNewsWire • 09/26/20
